Exact Mass: 354.0050046
Exact Mass Matches: 354.0050046
Found 141 metabolites which its exact mass value is equals to given mass value 354.0050046,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
THIODICARB
CONFIDENCE standard compound; INTERNAL_ID 457; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8163; ORIGINAL_PRECURSOR_SCAN_NO 8160 CONFIDENCE standard compound; INTERNAL_ID 457; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8215; ORIGINAL_PRECURSOR_SCAN_NO 8210 CONFIDENCE standard compound; INTERNAL_ID 457; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8251; ORIGINAL_PRECURSOR_SCAN_NO 8248 CONFIDENCE standard compound; INTERNAL_ID 457; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8269; ORIGINAL_PRECURSOR_SCAN_NO 8264
Win 56291
C16H16Cl2N2O3 (354.05379259999995)
Pipobroman
Pipobroman is only found in individuals that have used or taken this drug. It is an antineoplastic agent that acts by alkylation. [PubChem]The mechanism of action is uncertain but pipobroman is thought to alkylate DNA leading to disruption of DNA synthesis and eventual cell death. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D009676 - Noxae > D000477 - Alkylating Agents D000970 - Antineoplastic Agents
idoxuridine
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BB - Antivirals S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AD - Antivirals D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent Idoxuridine (5-Iodo-2′-deoxyuridine, 5-IUdR, IdUrd) is an iodinated thymidine analogue that competitively inhibits phosphorylases. Idoxuridine can inhibit viral activity, particularly viral eye infections, including herpes simplex keratitis, by inhibiting DNA polymerase and affecting viral replication. Idoxuridine against feline herpesvirus has the IC50 value of 4.3 μM[1]. Idoxuridine shows anti-orthopoxvirus activity.
Cyclovariegatin
Cyclovariegatin is found in mushrooms. Cyclovariegatin is isolated from sporophores of Suillus grevillei (larch bolete
Idoxuridine
Idoxuridine is only found in individuals that have used or taken this drug. It is an analog of deoxyuridine that inhibits viral DNA synthesis. The drug is used as an antiviral agent. [PubChem]Idoxuridine acts as an antiviral agent by inhibiting viral replication by substituting itself for thymidine in viral DNA. This in turn inhibits thymidylate phosphorylase and viral DNA polymerases from properly functioning. The effect of Idoxuridine results in the inability of the virus to reproduce or to infect/destroy tissue. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BB - Antivirals S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AD - Antivirals D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent Idoxuridine (5-Iodo-2′-deoxyuridine, 5-IUdR, IdUrd) is an iodinated thymidine analogue that competitively inhibits phosphorylases. Idoxuridine can inhibit viral activity, particularly viral eye infections, including herpes simplex keratitis, by inhibiting DNA polymerase and affecting viral replication. Idoxuridine against feline herpesvirus has the IC50 value of 4.3 μM[1]. Idoxuridine shows anti-orthopoxvirus activity.
Dihydronaringenin-O-sulphate
Dihydronaringenin-O-sulphate is a conjugate of dihydronaringenin and sulphate. Dihydronaringenin, also known as phloretin, is a dihydrochalcone, a type of natural phenols. It can be found in apple tree leaves. (Wikipedia)
5'-Iododeoxyuridine
Desacetylcephalothin
Diphosphoglucuronic acid
{3,5-Dichloro-4-[4-Hydroxy-3-(Propan-2-Yl)phenoxy]phenyl}acetic Acid
THIODICARB
uric acid citrate
XIPAMIDE
C15H15ClN2O4S (354.04410200000007)
C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BA - Sulfonamides, plain D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic D045283 - Natriuretic Agents > D004232 - Diuretics
(2S,4R,5S)-4,5,6-Trihydroxy-2-[hydroxy(phosphonooxy)phosphoryl]oxy-3-oxohexanoic acid
Apiforol sulfate
XIPAMIDE
C15H15ClN2O4S (354.04410200000007)
C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BA - Sulfonamides, plain D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic D045283 - Natriuretic Agents > D004232 - Diuretics
4,4,4-Trifluoro-2-(isothioureido-thiophen-3-yl-methyl)-3-oxo-butyric acid ethyl ester
C12H13F3N2O3S2 (354.03196640000004)
7-hydroxy-6-[(6,7-dihydroxy-2-oxo-2H-1-benzopyran-5-yl)oxy]-2H-1-benzopyran-2-one|dimeresculetin
2,5-DICHLORO-1-HYDROXY-3,6-DIMETHOXY-8-METHYL-9H-XANTHEN-9-ONE
2,4-Dichloro-1-hydroxy-3,6-dimethoxy-8-methyl-9H-xanthen-9-one
1,3-Dimethyl-2,4-dioxo-6-(methylsulfinyl)-1,2,3,4-tetrahydrothieno[3,2-g]pteridine-7-carboxylic acid
uracil 5-beta-D-fructofuranosyl-1-monophosphate
C10H15N2O10P (354.04643000000004)
(?)-agelastatin E|8a-O-methylagelastatin A|agelastatin E
Cyclovariegatin
Methyl 7-bromo-5-hydroxy-4,8-dimethoxy-6-methyl-2-naphthoate
Carbamic acid, (2-chloro-3-iodo-4-pyridinyl)-, 1,1-dimethylethyl ester (9CI)
C10H12ClIN2O2 (353.96320319999995)
n,n-ethylenebis(5-hydroxysalicylideneiminato)iron(ii)
3,4-Dihydro-2-(3-methoxypropyl)-4-oxo-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide
N1,N1-DIETHYL-5-CHLORO-2-(4-CHLOROPHENOXY)-4-NITROANILINE
C16H16Cl2N2O3 (354.05379259999995)
6-chloro-3-indolyl phosphate p-toluidine salt
C15H16ClN2O4P (354.05361760000005)
4,5-diamino-2-(4-bromo-2-chloroanilino)-3-fluorobenzonitrile
3-(4-BROMO-2-CHLOROPHENOXYMETHYL)-4-METHOXYBENZALDEHYDE
C15H12BrClO3 (353.96582920000003)
5-Bromo-2-Chloro-N-[2-(Ethylamino)-3-Pyridinyl]-3-Pyridinecarboxamide
ethyl 3-(2,3-difluoro-5-iodophenyl)-3-oxopropanoate
5,5,6,6,7,7,8,8,9,9,9-undecafluorononane-2,4-dione
Enisamium iodide
C14H15IN2O (354.02290899999997)
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C281 - Antiviral Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
tert-Butyl (6-chloro-4-iodopyridin-3-yl)carbamate
C10H12ClIN2O2 (353.96320319999995)
tert-butyl N-(2-chloro-4-iodopyridin-3-yl)carbamate
C10H12ClIN2O2 (353.96320319999995)
1-(2-bromo-4,5-difluorobenzenesulfonyl)-4-methylpiperazine
3-[2-(Diaminomethyleneamino)-1,3-thiazol-4-ylmethylsulphinyl]-N-sulphamoylpropanamide
C8H14N6O4S3 (354.02386440000004)
(3-Bromo-2-((2-chlorobenzyl)oxy)-5-methylphenyl)boronic acid
(3-Bromo-2-((4-chlorobenzyl)oxy)-5-methylphenyl)boronic acid
(3-Bromo-2-((3-chlorobenzyl)oxy)-5-methylphenyl)boronic acid
3-(2-BROMO-4-CHLOROPHENOXYMETHYL)-4-METHOXYBENZALDEHYDE
C15H12BrClO3 (353.96582920000003)
(4-BROMO-2,6-DICHLOROPHENOXY)(TERT-BUTYL)DIMETHYLSILANE
C12H17BrCl2OSi (353.96090319999996)
5-Deoxy-5-iodouridine
5'-Deoxy-5'-iodouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Uridine, 2-deoxy-5-iodo-
D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents
2-[(2,6-Dichlorophenyl)methylsulfanyl]-5-pyrazin-2-yl-1,3,4-thiadiazole
Yoda 1 is a potent and selective Piezo1 agonist. Yoda 1 activates purified Piezo1 channels. Yoda 1 potently inhibits macropinocytosis induced by epidermal growth factor (EGF). Yoda 1 enhances Ca2+ influx followed by activation of the calcium-activated potassium channel KCa3.1 and inhibition of Rac1 activation[1][2][3].
3-(3-bromo-4-hydroxy-5-methoxyphenyl)-2-cyano-N-(2-methoxyethyl)prop-2-enamide
Silane, 1,3,5-benzenetriyltris[chlorodimethyl-
C12H21Cl3Si3 (354.00165960000004)
2-[Carboxy-(2-thiophen-2-YL-acetylamino)-methyl]-5-methylene-5,6-dihydro-2H-[1,3]thiazine-4-carboxylic acid
(4S,8R)-2,20-dihydroxy-7,9,13-trioxapentacyclo[10.9.0.03,10.04,8.015,20]henicosa-1,3(10),5,11,15,17-hexaene-14,19,21-trione
2,4-Dihydroxy-3-oxo-5-phosphonooxy-2-(phosphonooxymethyl)pentanoic acid
3,7,8,10-Tetrahydroxy-1-methylbenzo[b]xanthene-6,11,12-trione
2,3,4-Trihydroxy-5-[hydroxy(phosphonooxy)phosphoryl]oxy-6-oxohexanoic acid
(2S,4R,5S)-4,5,6-Trihydroxy-2-[hydroxy(phosphonooxy)phosphoryl]oxy-3-oxohexanoic acid
2-(2,4-dichlorophenoxy)-N-(4-methyl-2-nitrophenyl)acetamide
C15H12Cl2N2O4 (354.01740920000003)
4-bromo-N-[(E)-quinoxalin-6-ylmethylidene]benzohydrazide
C16H11BrN4O (354.01161759999997)
2-bromo-N-[[(2-methylcyclohexyl)amino]-sulfanylidenemethyl]benzamide
3-[[(2,4-Dichloroanilino)-sulfanylidenemethyl]amino]-4-methylbenzoic acid
1-amino-2-(4-bromophenyl)-4,5-dihydro-3aH-pyrrolo[1,2-a]quinolin-3-one
2-[(E)-2-(3-bromophenyl)ethenyl]-8-nitroquinoline
C17H11BrN2O2 (354.00038459999996)
2-(3-Methoxybenzyl)-5-[5-(2-thienyl)-2-thienyl]-1,3,4-oxadiazole
(2S)-2-azaniumyl-5-({(2R)-1-[(carboxylatomethyl)amino]-3-[(chloromethyl)sulfanyl]-1-oxopropan-2-yl}amino)-5-oxopentanoate
1-(5-O-Phosphono-beta-D-ribofuranosyl)-5-amino-1H-imidazole-4-carbothioamide
C9H15N4O7PS (354.03990500000003)
(1R,5S)-3-[2-chloro-4-(methylsulfonyl)benzoyl]-4-hydroxybicyclo[3.2.1]oct-3-en-2-one
[3-(3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl)phenyl] hydrogen sulate
{4-[1-Oxo-1-(2,4,6-trihydroxyphenyl)propan-2-yl]phenyl}oxidanesulfonic acid
[4-(3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl)phenyl] hydrogen sulate
(2-benzyl-2,4,6-trihydroxy-3H-1-benzouran-3-yl) hydrogen sulate
3-[2-Chloro-4-(methylsulfonyl)benzoyl]-4-hydroxybicyclo[3.2.1]oct-3-en-2-one
2-(heptafluoropropyl)-6-(trifluoromethyl)-1H-benzimidazole
pipobroman
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D009676 - Noxae > D000477 - Alkylating Agents D000970 - Antineoplastic Agents
5-(3-(2,6-Dichloro-4-(4,5-Dihydro-2-Oxazolyl)phenoxy)propyl)-3-Methyl Isoxazole
C16H16Cl2N2O3 (354.05379259999995)
1-[(2R,5R)-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-5-iodopyrimidine-2,4-dione
2,4-dichlorolichexanthone
A member of the class of xanthones that is 9H-xanthen-9-one substituted by a hydroxy group at positions 1, chloro groups at positions 2 and 4, methoxy groups at positions 3 and 6 and a methyl group at position 8.
S-(chloromethyl)glutathione(1-)
A peptide anion obtained by deprotonation of both carboxy groups and protonation of the glutamyl amino group of S-(chloromethyl)glutathione; major species at pH 7.3.
5-BDBD
C17H11BrN2O2 (354.00038459999996)
5-BDBD, a potent and selective P2X4 receptor antagonist, inhibits rP2X4R-mediated currents, with an IC50 of 0.75 μM. 5-BDBD completely blocks the basal and acute hyperalgesia induced by nitroglycerin (NTG)[1][2].
(1r)-2-chloro-1,4,7-trihydroxy-3,9-dimethoxy-1-methyl-4h-benzo[c]chromen-6-one
C16H15ClO7 (354.05062699999996)
3-bromo-12-hydroxy-14-methoxy-13-methyl-2,8,11,13-tetraazatetracyclo[7.6.0.0²,⁶.0¹⁰,¹⁴]pentadeca-3,5,11-trien-7-one
2-chloro-1,4,7-trihydroxy-3,9-dimethoxy-1-methyl-4h-benzo[c]chromen-6-one
C16H15ClO7 (354.05062699999996)
{2,3,4-trihydroxy-5-[(4-hydroxy-2-oxopyrimidin-1-yl)methyl]oxolan-2-yl}methoxyphosphonic acid
C10H15N2O10P (354.04643000000004)
(4r,8r)-2,4,15,18-tetrahydroxy-7,9-dioxapentacyclo[10.8.0.0³,¹⁰.0⁴,⁸.0¹⁴,¹⁹]icosa-1,3(10),5,11,14,16,18-heptaene-13,20-dione
16-bromo-10-hydroxy-3,5,9,19-tetraazapentacyclo[10.7.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]nonadeca-1(12),2(6),4,7(11),9,13(18),14,16-octaen-8-one
4-[6-(3,4-dihydroxyphenyl)-2,5-dihydroxyfuro[3,2-b]furan-3-yl]cyclohexa-3,5-diene-1,2-dione
[(2r,3s,4s,5r)-2,3,4-trihydroxy-5-[(4-hydroxy-2-oxopyrimidin-1-yl)methyl]oxolan-2-yl]methoxyphosphonic acid
C10H15N2O10P (354.04643000000004)